Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Strategies for purging latently infected cells in HIV-positive patients studied at NIAID

Feb. 4, 1998

Promising efficacy reported at AIDS conference for amprenavir combinations

Feb. 3, 1998

Potent antiretroviral activity shown for abacavir + protease inhibitor in HIV-positive patients

Feb. 3, 1998

Swiss Remune trials initiated

Jan. 29, 1998

PMPA reduces viral load in phase I/II

Jan. 29, 1998

Triangle reports results from phase I/II FTC trial

Jan. 29, 1998

ACT evaluated in second phase I trial in HIV/AIDS patients

Jan. 28, 1998

New AIDS therapies in development in Korea

Jan. 28, 1998

Viracept approved for marketing in E.U. member countries

Jan. 23, 1998

Irreversible HIV protease inhibitors under evaluation at LG Chemical

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...